GLOBAL DIABETIC NEPHROPATHY MARKET WAS WORTH US$ 2.49 BN IN 2021, GROWING AT A CAGR OF 5.2% OVER THE FORECAST PERIOD (2022 – 2030): A REPORT BY ABSOLUTE MARKETS INSIGHTS
- erved to dramatically grow in prevalence concurrently with the rise in diabetes. The World Health Organization (WHO) has highlighted diabetes as a significant health issue in Asia, and as a result, health policies now place a high premium on its prevention. Thus to overcome the rising prelevance of diabetic nephropathy leading players in the market are investing into clinical trials for various treatments. Thus with advancements in treatments for diabetic nephropathy, the market is expected to tremendously flourish in the upcoming years.
- Some of the players operating in the global diabetic nephropathy market are AbbVie Inc., AstraZeneca, Bayer AG, ChemoCentryx, Inc., Genkyotex, Goldfinch Bio, Inc., Janssen Pharmaceutical Companies (Johnson & Johnson.), Mesoblast Ltd, Mitsubishi Tanabe Pharma Corporation, Novartis AG amongst others.
Request for customization to meet your precise research requirements: https://www.absolutemarketsinsights.com/request_for_customization.php?id=1229
Global Diabetic Nephropathy Market:
By Diabetics Type
- Type 1
- Type 2
By Diagnosis
- Urinary albumin test.
- Albumin/creatinine ratio
- Imaging tests
- Kidney biopsy
- Others
By Treatment
- Drug Treatment
- SGLT2 inhibitors
- Angiotensin converting enzyme (ACE) inhibitors
- Angiotensin receptor blockers (ARBs)
- Others
- Dietary Changes
- Dialysis
- Kidney Transplant
By End Users
- Hospitals And Clinics
- Diabetes Management Centers
- Research Institutes
By Region
- North America (U.S., Canada, Mexico, Rest of North America)
- Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
- Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific
- Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
- Latin America (Brazil, Argentina, Rest of Latin America)
Purchase the latest in-depth Global Diabetic Nephropathy Market Report @ https://www.absolutemarketsinsights.com/checkout?id=1229
Browse more trending reports by Absolute Markets Insights:
Biomarker In Diabetes Market - https://www.absolutemarketsinsights.com/reports/Biomarker-in-Diabetes-Market-2021---2029-897
Exosomes Market - https://www.absolutemarketsinsights.com/reports/Global-Exosomes-Market-2022---2030-1086
Companion Diagnostics for Oncology Market - https://www.absolutemarketsinsights.com/reports/Global-Companion-Diagnostics-for-Oncology-Market-2022---2030-1083
Point Of Care (PoC) Lipid Test Market - https://www.absolutemarketsinsights.com/reports/Point-of-Care-PoC-Lipid-Test-Market-2022-2029-1082
Glance through Absolute Markets Insights plethora of reports on Healthcare category.
About Us:
Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.
Contact Us:
Contact Name: Shreyas Tanna
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +91-7400-24-24-24, US +1-510-420-1213
Website: www.absolutemarketsinsights.com
Comments
Post a Comment